부가기능
Brief report Minimal residual disease-based role of imatinib as a first-line interim therapy prior to allogeneic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia/
기사 상세정보
서평
서평등록 중 오류가 발생하였습니다. 재시도 하십시오.